Pete De Spain | VP, IR & Corporate Communications |
Troy Wilson | President & CEO |
Heidi Henson | CFO |
Antonio Gualberto | Chief Medical Officer |
Good day, ladies and gentlemen, and welcome to Kura Oncology Incorporated Fourth Quarter 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will be provided at that time. [Operator Instructions] As a reminder, this conference call is being recorded.
Now I'd like to introduce your host for today's conference, Pete De Spain, VP of Investor Relations.